688799 华纳药厂
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.42512.73011.88615.00723.849
总资产报酬率 ROA (%)2.70310.0979.60511.82616.364
投入资产回报率 ROIC (%)3.22112.04411.34314.50523.514

边际利润分析
销售毛利率 (%)64.30064.78567.71272.38573.122
营业利润率 (%)18.08016.54915.16315.86416.923
息税前利润/营业总收入 (%)17.76315.18414.49415.35617.247
净利润/营业总收入 (%)14.11513.47313.41314.02115.256

收益指标分析
经营活动净收益/利润总额(%)75.60996.90293.02291.01694.325
价值变动净收益/利润总额(%)-4.2261.5594.0910.948-3.826
营业外收支净额/利润总额(%)-0.008-3.147-0.534-1.0342.190

偿债能力分析
流动比率 (X)4.0934.0134.2344.6461.892
速动比率 (X)3.0252.9343.0833.4881.051
资产负债率 (%)19.65818.77417.43917.69528.017
带息债务/全部投入资本 (%)3.6372.3762.068-0.114-2.603
股东权益/带息债务 (%)2,572.1593,980.9374,575.411-84,720.728-3,743.883
股东权益/负债合计 (%)400.326421.701455.722465.140256.925
利息保障倍数 (X)-56.427-17.654-24.640-44.472-310.105

营运能力分析
应收账款周转天数 (天)40.42439.24738.76236.98037.531
存货周转天数 (天)247.149250.413275.918277.521267.127